Evidence against vasoactive intestinal polypeptide being the non-adrenergic, non-cholinergic inhibitory transmitter released from nerves supplying the smooth muscle of the guinea-pig taenia coli

European Journal of Pharmacology
I Mackenzie, G Burnstock

Abstract

Vasoactive intestinal polypeptide (VIP), located within intrinsic neurones of the guinea-pig taenia coli, has been proposed as a neurotransmitter which may mediate certain non-adrenergic, non-cholinergic effects within the gastrointestinal tract. The relaxation of the taenia coli produced by exogenous VIP has a longer latency and time to maximum than the relaxation which is obtained during electrical stimulation of the non-adrenergic, non-cholinergic nerves. The responses to exogenous VIP (0.03-1 microM) were abolished by the proteolytic enzyme alpha-chymotrypsin (1 U/ml), whereas there were no statistically significant changes in the inhibitory responses to intramural nerve stimulation (0.1-5 Hz) or exogenous ATP (0.03-100 microM), which closely mimics the nerve-mediated response. Apamin is a neurotoxin which prevents the increase in K+ conductance associated with the inhibitory junction potential produced by stimulation of the non-adrenergic, non-cholinergic inhibitory nerves. In the presence of apamin (0.005-1 microM) the responses to intramural nerve stimulation and exogenous ATP were significantly antagonised, and often converted to contractile responses. The VIP-induced relaxations during apamin treatment were not signifi...Continue Reading

References

Dec 1, 1978·Acta Physiologica Scandinavica·J M LundbergS Said
Oct 1, 1979·Acta Physiologica Scandinavica·R EdinJ Kewenter
Oct 12, 1979·Brain Research·J T Williams, R A North
Sep 15, 1979·European Journal of Pharmacology·A J Maas, A Den Hertog
Mar 2, 1978·Histochemistry·F SundlerO Schaffalitzky de Muckadell
Jan 1, 1978·Neir̆ofiziologiia = Neurophysiology·I A Vladimirova, M F Shuba
Jan 22, 1971·Nature·G Burnstock
Jul 1, 1973·Acta Physiologica Scandinavica·H Abrahamsson, G Jansson
Jan 1, 1969·Acta Physiologica Scandinavica·G Jansson
May 1, 1966·British Journal of Pharmacology and Chemotherapy·T M Gilfoil, C A Kelly
Jun 1, 1967·The Journal of Cell Biology·M R Bennett, D C Rogers
Apr 10, 1980·Nature·T HökfeltM Schultzberg
Jan 1, 1980·Neuroscience·J B Furness, M Costa
Aug 1, 1976·Neuroscience·G Burnstock

❮ Previous
Next ❯

Citations

Jun 1, 1993·Pflügers Archiv : European journal of physiology·V P ZagorodnyukG Burnstock
Jan 1, 1986·Naunyn-Schmiedeberg's Archives of Pharmacology·M CostaC M Humphreys
Feb 1, 1989·Digestive Diseases and Sciences·T TakahashiJ Utsunomiya
Oct 1, 1987·Agents and Actions·M E ZacourJ G Martin
Apr 1, 1989·Diseases of the Colon and Rectum·M LorentzenJ Christiansen
Oct 1, 1984·European Journal of Pharmacology·I Mackenzie, G Burnstock
Aug 7, 1985·European Journal of Pharmacology·R J Altiere, L Diamond
Nov 6, 1990·European Journal of Pharmacology·G E BoeckxstaensY M Van Maercke
Jan 1, 1984·Pharmacology & Therapeutics·E Habermann
Jan 1, 1988·Pharmacology & Therapeutics·T D White
Jan 1, 1989·Pharmacology & Therapeutics·G S Taylor, R A Bywater
Jun 1, 1989·Journal of the Autonomic Nervous System·C L ProsserL Barr
Oct 1, 1987·Regulatory Peptides·A BelaiG Burnstock
Jan 1, 1983·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·S Holmgren
Jan 1, 1994·Baillière's Clinical Endocrinology and Metabolism·K McConalogue, J B Furness
Aug 24, 1999·British Journal of Pharmacology·C W ShuttleworthK M Sanders
Apr 1, 1992·Journal of Autonomic Pharmacology·F MulèA Postorino
Jul 1, 1996·The Journal of Clinical Investigation·H MashimoR K Goyal
Apr 18, 2008·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·G Burnstock
Jul 1, 1993·Scandinavian Journal of Gastroenterology·H SchwörerW E Schmidt
Apr 1, 1983·The Journal of Pharmacy and Pharmacology·D E Burleigh
Nov 15, 2016·Frontiers in Physiology·Arun ChaudhuryWasique Mirza
Jan 1, 1985·Scandinavian Journal of Gastroenterology. Supplement·E Lyrenäs

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.